Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Finch Therapeutics Number of Employees 2021-2023 | FNCH

Finch Therapeutics number of employees from 2021 to 2023. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
  
Finch Therapeutics Annual Employee Count
2023 1
2022 18
2021 189
2020
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.004B $0.000B
Finch Therapeutics Group Inc. is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. The company's product candidate includes CP101, FIN-211, FIN-524 and FIN-525. Finch Therapeutics Group Inc. is based in SOMERVILLE, Mass.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.455B 29.78
Chugai Pharmaceutical (CHGCY) Japan $50.600B 22.62
Takeda Pharmaceutical (TAK) Japan $41.238B 6.68
Merck (MKGAF) Germany $20.301B 19.16
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Shionogi (SGIOY) Japan $14.324B 12.39
Sandoz Group AG (SDZNY) Switzerland $14.137B 0.00
Neurocrine Biosciences (NBIX) United States $13.532B 56.19
United Therapeutics (UTHR) United States $11.005B 11.79
Catalent (CTLT) United States $10.120B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.712B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.896B 6.99
Ionis Pharmaceuticals (IONS) United States $6.062B 0.00
Revolution Medicines (RVMD) United States $5.922B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.847B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.932B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.741B 0.00
Summit Therapeutics (SMMT) United States $2.709B 0.00
Indivior (INDV) United States $2.424B 11.49
Corcept Therapeutics (CORT) United States $2.373B 24.00
PTC Therapeutics (PTCT) United States $2.189B 0.00
Dyne Therapeutics (DYN) United States $2.131B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.963B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.905B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.802B 10.67
Evotec AG (EVO) Germany $1.779B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.757B 18.16
Avadel Pharmaceuticals (AVDL) Ireland $1.613B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.89
Ardelyx (ARDX) United States $1.494B 0.00
Soleno Therapeutics (SLNO) United States $1.266B 0.00
Xencor (XNCR) United States $1.232B 0.00
Pacira BioSciences (PCRX) United States $1.225B 12.19
Ironwood Pharmaceuticals (IRWD) United States $1.224B 11.50
Collegium Pharmaceutical (COLL) United States $1.191B 7.33
4D Molecular Therapeutics (FDMT) United States $1.189B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Cassava Sciences (SAVA) United States $0.966B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
Relay Therapeutics (RLAY) United States $0.843B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Sage Therapeutics (SAGE) United States $0.824B 0.00
ARS Pharmaceuticals (SPRY) United States $0.806B 0.00
Enliven Therapeutics (ELVN) United States $0.804B 0.00
Ocular Therapeutix (OCUL) United States $0.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
Siga Technologies (SIGA) United States $0.625B 9.25
Savara (SVRA) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.581B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.525B 0.00
Verve Therapeutics (VERV) United States $0.515B 0.00
Altimmune (ALT) United States $0.515B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Exscientia (EXAI) United Kingdom $0.487B 0.00
ProKidney (PROK) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Larimar Therapeutics (LRMR) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Harrow (HROW) United States $0.372B 0.00
Heron Therapeutics (HRTX) United States $0.368B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.53
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.321B 0.00
Bioventus (BVS) United States $0.315B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Black Diamond Therapeutics (BDTX) United States $0.309B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.282B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.281B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.269B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.231B 0.00
Prelude Therapeutics (PRLD) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
CytoDyn (CYDY) United States $0.142B 0.00
Elite Pharmaceuticals (ELTP) United States $0.142B 13.25
Incannex Healthcare (IXHL) Australia $0.141B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.120B 2.51
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Eliem Therapeutics (ELYM) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
GlycoMimetics (GLYC) United States $0.106B 0.00
Inotiv (NOTV) United States $0.104B 0.00
FibroGen (FGEN) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 6.37
Tempest Therapeutics (TPST) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
JanOne (JAN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
DURECT (DRRX) United States $0.029B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 11.73
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.42